Peripheral Artery Disease Market to Surpass USD 10.5 Billion by 2034 on Back of Endovascular Innovation and Elderly Patient Growth

The global peripheral artery disease market is expected to grow steadily over the next decade. Valued at USD 5.11 billion in 2024, it is projected to reach USD 10.53 billion by 2034, expanding at a compound annual growth rate (CAGR) of 7.5%.

This growth is driven by greater awareness of cardiovascular health, technological innovations in treatment, and the rising number of older adults and people with chronic conditions like diabetes—groups that are more susceptible to PAD.

PAD is a condition where arteries, typically in the legs, become narrowed due to plaque buildup. This limits blood flow and, if left untreated, increases the risk of heart attack, stroke, and even limb amputation. As global rates of PAD rise, healthcare systems are investing more in accurate diagnosis, minimally invasive interventions, and long-term management solutions.

Key Factors Driving Growth

  1. Lifestyle Diseases Are Fueling PAD Cases


Rising rates of diabetes, obesity, hypertension, and tobacco use are contributing to the growing number of PAD cases. These chronic conditions increase cardiovascular risk and, in turn, demand for early diagnosis and advanced treatment options.

  1. Aging Populations


PAD is more common among older individuals. Countries such as Japan, Germany, Italy, and the United States—all with aging populations—are experiencing a steady rise in PAD diagnoses. This demographic trend ensures consistent demand for therapies and procedures that address PAD.

  1. Advances in Treatment Technologies


The development of devices like drug-coated balloons, drug-eluting stents, atherectomy systems, and bioresorbable scaffolds has significantly improved treatment outcomes. These tools help restore blood flow and reduce the likelihood of arteries narrowing again. Companies like MedtronicAbbott, and Boston Scientific are leading the way with innovations in this area.

  1. Shift Toward Minimally Invasive Procedures


Patients and healthcare providers increasingly prefer less invasive treatments that offer quicker recovery and fewer complications. Many PAD procedures can now be performed in outpatient clinics, reducing the burden on hospitals.

  1. Improved Insurance Coverage and Awareness


In developed countries, insurance reimbursement policies are expanding to cover PAD-related diagnostics and treatments. Public health organizations are also running awareness campaigns to encourage early detection and timely intervention.

Explore The Complete Comprehensive Report Here:

https://www.polarismarketresearch.com/industry-analysis/peripheral-artery-disease-market 

Challenges Impacting the Market

  1. Low Awareness and Underdiagnosis


PAD is often misdiagnosed as arthritis or nerve-related issues, particularly in low- and middle-income countries. This delays treatment and limits patient access to available therapies.

  1. High Costs and Limited Access in Developing Regions


While new therapies are promising, their high cost and the lack of trained specialists remain barriers in developing regions. Many patients in Asia, Africa, and Latin America face difficulties in accessing quality vascular care.

  1. Long-Term Safety Concerns


Some newer technologies still lack long-term clinical data, and risks such as restenosis (re-narrowing of arteries) or device failure persist. These concerns can slow adoption among more conservative healthcare providers.

Regional Market Overview

North America

The region leads the global PAD market. In the United States, well-established healthcare infrastructure, widespread awareness, and strong insurance support contribute to high diagnosis and treatment rates.

Europe

Countries like Germany, the UK, and France have robust health systems and national screening programs that support PAD detection and treatment, driving steady market growth.

Asia-Pacific

This region is expected to grow the fastest. Nations such as China, India, Japan, and South Korea are investing heavily in healthcare infrastructure and improving access to diagnostics and interventional tools.

Latin America, Middle East & Africa

Adoption is gradually increasing in markets like Brazil, Saudi Arabia, and South Africa, but limited access, cost constraints, and infrastructure gaps continue to hinder broader market penetration.

Major Companies in the PAD Market

Several key players are driving innovation, market expansion, and clinical research:

  • Abbott – Known for a wide range of stents, balloons, and vascular imaging tools.

  • Medtronic – Offers a complete line of catheters and advanced stents.

  • Boston Scientific – Specializes in drug-coated and atherectomy devices.

  • Bayer AG – Focuses on pharmaceutical treatments for PAD.

  • Biotronik – Develops drug-coated balloons and stents.

  • Philips – Provides advanced imaging systems that assist in PAD diagnosis and treatment.

  • Other notable players include BD, B. Braun, Cardinal Health, Johnson & Johnson, Terumo, iVascular, and Endologix.


What’s Next for PAD Treatment?

Looking ahead, the PAD market is expected to evolve through:

  • Development of next-generation drug-device combinations

  • Use of bioresorbable materials for stents

  • Adoption of AI-powered diagnostics and robot-assisted procedures

  • Introduction of wearable vascular health monitors for long-term care


As healthcare systems shift toward outpatient and personalized care, these advances will make PAD treatment more effective, less invasive, and more widely accessible.

Conclusion

The global peripheral artery disease market is on track for strong growth over the next decade. Driven by demographic shifts, rising chronic disease rates, and rapid medical innovation, the global demand for PAD treatments will only continue to rise.

While challenges such as underdiagnosis and treatment affordability remain—particularly in developing regions—the overall outlook is highly positive. With major healthcare companies leading the way, PAD treatments are becoming smarter, safer, and more accessible.

More Trending Latest Reports By Polaris Market Research:

Sterility Testing Market

Podcast Advertising Market

Frozen Food Market

Parkinson’s Disease Treatment Market

Europe Textile Chemicals Market

Network Monitoring Market

Mobile Virtual Network Operator (MVNO) Market

Ambulatory Care Services Market

Parkinson’s Disease Treatment Market

Direct Energy Conversion Device Market

CBRN Defense Market

Access Control System Market

Heat Exchangers Market

Glass Substrate Market

Network Monitoring Market

Wireless Mesh Network Market

Hemodynamic Monitoring Devices Market

Heat Exchangers Market

Leave a Reply

Your email address will not be published. Required fields are marked *